SCHEMBL8714064

SCHEMBL8714064

Fc1cc2c3c(cccc3c1)C=C2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.39
CYP2A6 P11509 1/20 0.39
ALDH1A1 P00352 3/20 0.32
MCL1 Q07820 2/20 0.32
MEN1 O00255 1/20 0.32
DNMT1 P26358 1/20 0.32
CACNA1B Q00975 1/20 0.32
APBA1 Q02410 1/20 0.32
KMT2A Q03164 1/20 0.32
APOBEC3G Q9HC16 1/20 0.32
CYP1A1 P04798 2/20 0.32
CYP1B1 Q16678 2/20 0.32
CYP3A4 P08684 1/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32
HSD17B10 Q99714 1/20 0.32
CES2 O00748 1/20 0.30
BCHE P06276 1/20 0.30
CES1 P23141 1/20 0.30
ACHE P22303 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26037 0.77 ALDH1A1 (0.53) CYP1A2CYP2A6ALDH1A1MCL1MEN1
SCHEMBL8872842 0.77 ALDH1A1 (0.53) CYP1A2CYP2A6ALDH1A1MCL1MEN1
SCHEMBL29575794 0.77 ALDH1A1 (0.53) CYP1A2CYP2A6ALDH1A1MCL1MEN1
SCHEMBL8766388 0.76 ALDH1A1 (0.31) CYP1A2ALDH1A1MCL1MEN1DNMT1
SCHEMBL5033508 0.76 CYP2A6 (0.38) CYP1A2CYP2A6ALDH1A1MCL1MEN1
SCHEMBL120783 0.76 ALDH1A1 (0.40) CYP1A2ALDH1A1MCL1MEN1DNMT1
SCHEMBL551412 0.76 NPSR1 (0.42) CYP1A2CYP2A6ALDH1A1MCL1MEN1
SCHEMBL5031545 0.76 CYP1A2 (0.39) CYP1A2CYP2A6ALDH1A1MCL1MEN1
SCHEMBL5372675 0.76 ALDH1A1 (0.31) CYP1A2ALDH1A1MCL1MEN1DNMT1
SCHEMBL5376089 0.76 MPO (0.41) CYP1A2ALDH1A1MCL1MEN1DNMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5847006-A Therapeutic guanidines CAMBRIDGE NEUROSCIENCE, INC. (US) 1998-12-08 US disclosed
EP-0746316-A4 THERAPEUTIC GUANIDINES CAMBRIDGE NEUROSCIENCE INC (US) 1997-12-10 EP disclosed
EP-0505972-B1 Process for producing styrenic copolymer IDEMITSU KOSAN CO (JP) 1997-06-11 EP disclosed
EP-0746316-A1 THERAPEUTIC GUANIDINES CAMBRIDGE NEUROSCIENCE, INC. (US) 1996-12-11 EP disclosed
WO-1995014467-A1 THERAPEUTIC GUANIDINES CAMBRIDGE NEUROSCIENCE, INC. (US) 1995-06-01 WO disclosed
EP-0505972-A2 Process for producing styrenic copolymer IDEMITSU KOSAN COMPANY LIMITED (JP) 1992-09-30 EP disclosed